|Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer|
H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ...
Nature medicine 22 (3), 298-305, 2016
|Ontology visualization methods—a survey|
A Katifori, C Halatsis, G Lepouras, C Vassilakis, E Giannopoulou
ACM Computing Surveys (CSUR) 39 (4), 10-es, 2007
|Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH|
J Yun, E Mullarky, C Lu, KN Bosch, A Kavalier, K Rivera, J Roper, IIC Chio, ...
Science 350 (6266), 1391-1396, 2015
|The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer|
D Chakravarty, A Sboner, SS Nair, E Giannopoulou, R Li, S Hennig, ...
Nature communications 5 (1), 1-16, 2014
|Synergistic activation of inflammatory cytokine genes by interferon-γ-induced chromatin remodeling and toll-like receptor signaling|
Y Qiao, EG Giannopoulou, CH Chan, S Park, S Gong, J Chen, X Hu, ...
Immunity 39 (3), 454-469, 2013
|Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation|
X Su, Y Yu, Y Zhong, EG Giannopoulou, X Hu, H Liu, JR Cross, G Rätsch, ...
Nature immunology 16 (8), 838-849, 2015
|Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression|
PC Lin, YL Chiu, S Banerjee, K Park, JM Mosquera, E Giannopoulou, ...
Cancer research 73 (3), 1232-1244, 2013
|Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation|
R Popovic, E Martinez-Garcia, EG Giannopoulou, Q Zhang, Q Zhang, ...
PLoS Genet 10 (9), e1004566, 2014
|NFIB is a governor of epithelial–melanocyte stem cell behaviour in a shared niche|
CY Chang, HA Pasolli, EG Giannopoulou, G Guasch, RM Gronostajski, ...
Nature 495 (7439), 98-102, 2013
|A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters|
K Hatzi, Y Jiang, C Huang, F Garrett-Bakelman, MD Gearhart, ...
Cell reports 4 (3), 578-588, 2013
|Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two …|
SD Garbis, SI Tyritzis, T Roumeliotis, P Zerefos, EG Giannopoulou, ...
The Journal of Proteome Research 7 (8), 3146-3158, 2008
|Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation|
SH Park, K Kang, E Giannopoulou, Y Qiao, K Kang, G Kim, KH Park-Min, ...
Nature immunology 18 (10), 1104, 2017
|An integrated ChIP-seq analysis platform with customizable workflows|
EG Giannopoulou, O Elemento
BMC bioinformatics 12 (1), 277, 2011
|Modulation of TNF-induced macrophage polarization by synovial fibroblasts|
LT Donlin, A Jayatilleke, EG Giannopoulou, GD Kalliolias, LB Ivashkiv
The Journal of Immunology 193 (5), 2373-2383, 2014
|Inhibition of osteoclastogenesis and inflammatory bone resorption by targeting BET proteins and epigenetic regulation|
KH Park-Min, E Lim, MJ Lee, SH Park, E Giannopoulou, A Yarilina, ...
Nature communications 5 (1), 1-9, 2014
|Interferon-γ represses M2 gene expression in human macrophages by disassembling enhancers bound by the transcription factor MAF|
K Kang, SH Park, J Chen, Y Qiao, E Giannopoulou, K Berg, A Hanidu, J Li, ...
Immunity 47 (2), 235-250. e4, 2017
|Epigenomic alterations in localized and advanced prostate cancer|
PC Lin, EG Giannopoulou, K Park, JM Mosquera, A Sboner, AK Tewari, ...
Neoplasia 15 (4), 373-IN5, 2013
|The transcriptional modulator BCL6 as a molecular target for breast cancer therapy|
SR Walker, S Liu, M Xiang, M Nicolais, K Hatzi, E Giannopoulou, ...
Oncogene 34 (9), 1073-1082, 2015
|RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis|
S Li, CH Miller, E Giannopoulou, X Hu, LB Ivashkiv, B Zhao
The Journal of clinical investigation 124 (11), 5057-5073, 2014
|CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells|
C Delehouzé, K Godl, N Loaëc, C Bruyère, N Desban, N Oumata, ...
Oncogene 33 (50), 5675-5687, 2014